FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205643111> ?p ?o ?g. }

• W4205643111 endingPage "41" @default.
• W4205643111 startingPage "32" @default.
• W4205643111 abstract "Objective: to compare changes in estimated glomerular filtration rate (eGFR) in liver recipients with initially normal and impaired eGFR within the first year after immunosuppression conversion. Materials and methods. Enrolled in the study were 215 recipients of deceased-donor livers from February 2009 to February 2020, who received everolimus with dose reduction or complete withdrawal of calcineurin inhibitors (immunosuppression conversion, ISxC) for varying periods of time. GFR was measured using the MDRD-4 formula immediately before ISxC, then 3, 6, and 12 months after orthotopic liver transplantation (LTx). One month was considered an acceptable temporary deviation from the corresponding point. Results. At the time of ISxC, 32 (15%) of 215 recipients had normal renal function. Chronic kidney disease (CKD) increased in 60% of the recipients with normal eGFR by the end of the first year following ISxC; the fall in eGFR was particularly pronounced in older recipients. In the group with a baseline eGFR of 60–89 mL/min/1.73 m2, eGFR normalized in 62% of cases within 12 months; 28% of cases had no changes in renal function. In the subgroup with a pronounced decrease in eGFR at the time of ISxC, increased eGFR was observed as early as 1 month after ISxC, and the maximum was recorded after 3–6 months. The mean eGFR relative to baseline by month 3 after eGFR were higher for ISxC that was done in the first 2 months after LTx (19.7 ± 15.7 ml/minute/1.73 m2) than for ISxC done in the long-term period after LTx (10.1 ± 8.7 ml/minute/1.73 m2, p < 0.05). Conclusion. Changes in eGFR in liver recipients receiving EVR plus low-dose calcineurin inhibitor (CNI) depend on baseline eGFR and are multidirectional. The use of ISxC in the early post-LTx period led to a more pronounced improvement in eGFR. Maximal changes in eGFR were observed by 3–6 months after ISxC." @default.
• W4205643111 created "2022-01-26" @default.
• W4205643111 creator A5005505862 @default.
• W4205643111 creator A5041328662 @default.
• W4205643111 creator A5048953814 @default.
• W4205643111 creator A5075884619 @default.
• W4205643111 date "2021-10-22" @default.
• W4205643111 modified "2023-10-16" @default.
• W4205643111 title "Changes in glomerular filtration rate in liver recipients after reduced exposure to calcineurin inhibitors with concomitant everolimus administration within the first year after immunosuppression conversion" @default.
• W4205643111 cites W1487322250 @default.
• W4205643111 cites W1550111394 @default.
• W4205643111 cites W1591245977 @default.
• W4205643111 cites W1987093366 @default.
• W4205643111 cites W1996468254 @default.
• W4205643111 cites W2055864845 @default.
• W4205643111 cites W2066405947 @default.
• W4205643111 cites W2068718128 @default.
• W4205643111 cites W2073742622 @default.
• W4205643111 cites W2134672034 @default.
• W4205643111 cites W2775405622 @default.
• W4205643111 cites W3005532329 @default.
• W4205643111 cites W3048330533 @default.
• W4205643111 doi "https://doi.org/10.15825/25/1995-1191-2021-4-32-41" @default.
• W4205643111 hasPublicationYear "2021" @default.
• W4205643111 type Work @default.
• W4205643111 citedByCount "1" @default.
• W4205643111 countsByYear W42056431112023 @default.
• W4205643111 crossrefType "journal-article" @default.
• W4205643111 hasAuthorship W4205643111A5005505862 @default.
• W4205643111 hasAuthorship W4205643111A5041328662 @default.
• W4205643111 hasAuthorship W4205643111A5048953814 @default.
• W4205643111 hasAuthorship W4205643111A5075884619 @default.
• W4205643111 hasBestOaLocation W42056431111 @default.
• W4205643111 hasConcept C126322002 @default.
• W4205643111 hasConcept C126894567 @default.
• W4205643111 hasConcept C128057223 @default.
• W4205643111 hasConcept C159641895 @default.
• W4205643111 hasConcept C2778653478 @default.
• W4205643111 hasConcept C2779384505 @default.
• W4205643111 hasConcept C2779609443 @default.
• W4205643111 hasConcept C2779699572 @default.
• W4205643111 hasConcept C2780252810 @default.
• W4205643111 hasConcept C2911091166 @default.
• W4205643111 hasConcept C71924100 @default.
• W4205643111 hasConcept C90924648 @default.
• W4205643111 hasConceptScore W4205643111C126322002 @default.
• W4205643111 hasConceptScore W4205643111C126894567 @default.
• W4205643111 hasConceptScore W4205643111C128057223 @default.
• W4205643111 hasConceptScore W4205643111C159641895 @default.
• W4205643111 hasConceptScore W4205643111C2778653478 @default.
• W4205643111 hasConceptScore W4205643111C2779384505 @default.
• W4205643111 hasConceptScore W4205643111C2779609443 @default.
• W4205643111 hasConceptScore W4205643111C2779699572 @default.
• W4205643111 hasConceptScore W4205643111C2780252810 @default.
• W4205643111 hasConceptScore W4205643111C2911091166 @default.
• W4205643111 hasConceptScore W4205643111C71924100 @default.
• W4205643111 hasConceptScore W4205643111C90924648 @default.
• W4205643111 hasIssue "4" @default.
• W4205643111 hasLocation W42056431111 @default.
• W4205643111 hasLocation W42056431112 @default.
• W4205643111 hasOpenAccess W4205643111 @default.
• W4205643111 hasPrimaryLocation W42056431111 @default.
• W4205643111 hasRelatedWork W1997245814 @default.
• W4205643111 hasRelatedWork W2022636322 @default.
• W4205643111 hasRelatedWork W2039007959 @default.
• W4205643111 hasRelatedWork W2054171816 @default.
• W4205643111 hasRelatedWork W2135891013 @default.
• W4205643111 hasRelatedWork W2328872699 @default.
• W4205643111 hasRelatedWork W2330154650 @default.
• W4205643111 hasRelatedWork W2397174767 @default.
• W4205643111 hasRelatedWork W2548660892 @default.
• W4205643111 hasRelatedWork W4205643111 @default.
• W4205643111 hasVolume "23" @default.
• W4205643111 isParatext "false" @default.
• W4205643111 isRetracted "false" @default.
• W4205643111 workType "article" @default.